Gene Therapy - New Challenges Ahead

Science

Volumn 302, Issue 5644, 2003, Pages 400-401

  Williams, David A ^a   Baum, Christopher ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR; DNA BINDING PROTEIN; LMO2 PROTEIN, HUMAN; METALLOPROTEIN;

COMBINED IMMUNODEFICIENCY; GENE THERAPY; GENE TRANSFER; GENOTOXICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; STEM CELL TRANSPLANTATION; T CELL LEUKEMIA; TRANSGENE; CLINICAL TRIAL; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INFANT; NOTE; PHYSIOLOGY; PROTO ONCOGENE; RISK FACTOR; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE;

UNIDENTIFIED RETROVIRUS;

CLINICAL TRIALS; DNA-BINDING PROTEINS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; LEUKEMIA, T-CELL, ACUTE; METALLOPROTEINS; MUTAGENESIS, INSERTIONAL; PROTO-ONCOGENES; RECEPTORS, INTERLEUKIN-2; RETROVIRIDAE; RISK FACTORS; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES; TRANSGENES;

EID: 0242367234     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1091258     Document Type: Review

References (10)

1. S. Hacein-Bey-Abina et al., N. Engl. J. Med. 346, 1185 (2002).
2. A. Aiuti et al., Science 296, 2410 (2002).
3. S. Hacein-Bey-Abina et al., Science 302, 415 (2003).
4. C. Baum et al., Blood 101, 2099 (2003).
5. D. Kohn et al., Mol. Ther. 8, 180 (2003).
6. A. R. Schroder et al., Cell 110, 521 (2002).
7. X. Wu, Y. Li, B. Crise, S. M. Burgess, Science 300, 1749 (2003).
8. Z. Li et al., Science 296, 497 (2002).
9. M. Schmidt et al., Blood 100, 2737 (2002).
10. Supported by the Deutsche Forschungsgemeinschaft (KFO 110) and European Union (QLRT-2001-00427 and QLK3-2001-01265) (C.B.) and NIH (HL53586) (D.A.W.).